A detailed history of Crestwood Advisors Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 222,338 shares of ZTS stock, worth $39.2 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
222,338
Previous 221,645 0.31%
Holding current value
$39.2 Million
Previous $38.4 Million 13.05%
% of portfolio
0.86%
Previous 0.81%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$172.58 - $196.48 $119,597 - $136,160
693 Added 0.31%
222,338 $43.4 Million
Q2 2024

Aug 01, 2024

BUY
$145.54 - $178.83 $305,051 - $374,827
2,096 Added 0.95%
221,645 $38.4 Million
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $529,812 - $639,408
3,198 Added 1.48%
219,549 $37.1 Million
Q4 2023

Jan 29, 2024

BUY
$151.44 - $200.09 $223,979 - $295,933
1,479 Added 0.69%
216,351 $42.7 Million
Q3 2023

Nov 15, 2023

BUY
$167.14 - $192.77 $364,866 - $420,816
2,183 Added 1.03%
214,872 $37.4 Million
Q2 2023

Aug 15, 2023

BUY
$160.94 - $186.23 $361,632 - $418,458
2,247 Added 1.07%
212,689 $36.6 Million
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $5.14 Million - $6.18 Million
-35,298 Reduced 14.36%
210,442 $35 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $129,435 - $155,422
-987 Reduced 0.4%
245,740 $36 Million
Q3 2022

Oct 26, 2022

BUY
$148.29 - $182.55 $1.17 Million - $1.44 Million
7,901 Added 3.31%
246,727 $36.6 Million
Q2 2022

Jul 07, 2022

BUY
$155.97 - $200.09 $5.17 Million - $6.64 Million
33,164 Added 16.13%
238,826 $41.1 Million
Q1 2022

Apr 12, 2022

BUY
$181.39 - $234.03 $769,819 - $993,223
4,244 Added 2.11%
205,662 $38.8 Million
Q4 2021

Feb 15, 2022

SELL
$193.69 - $247.03 $546,593 - $697,118
-2,822 Reduced 1.38%
201,418 $49.2 Million
Q3 2021

Nov 03, 2021

SELL
$189.29 - $209.69 $197,050 - $218,287
-1,041 Reduced 0.51%
204,240 $39.7 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $603,800 - $728,085
3,873 Added 1.92%
205,281 $38.3 Million
Q1 2021

Apr 21, 2021

BUY
$144.0 - $169.39 $1.11 Million - $1.3 Million
7,692 Added 3.97%
201,408 $31.7 Million
Q4 2020

Feb 09, 2021

BUY
$157.07 - $174.35 $1.06 Million - $1.17 Million
6,734 Added 3.6%
193,716 $32.1 Million
Q3 2020

Oct 06, 2020

BUY
$137.1 - $165.37 $273,240 - $329,582
1,993 Added 1.08%
186,982 $30.9 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $1.23 Million - $1.57 Million
-11,034 Reduced 5.63%
184,989 $25.4 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $5.56 Million - $8.69 Million
59,963 Added 44.07%
196,023 $23.1 Million
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $317,827 - $364,305
2,734 Added 2.05%
136,060 $18 Million
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $15 Million - $17.1 Million
133,326 New
133,326 $16.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.